Lab News

We were very pleased to present our field of radiopharmaceutical sciences to all our collegues as part of the Agora Progress Report series. Many thanks to all attendees for the great interest, the good discussions and the positive feedback!

We congratulate our PhD student Sebastian for his travel award and his talk at the iSRS2022 symposium in Nantes. 

Fête Noël at Café Pointu. 

A new summarizing review in regard of CXCR4 immune cell orchestration, its potential for therapy and imaging is published now:

In Vivo Targeting of CXCR4—New Horizons

We welcome Alexandra in our research group. With her as an experienced radiopharmacist our team is complete for '21 and we will be ready to take off for the following year(s) to present you first exclusive insights of our results. 

Check out our most recent publication concerning hybrid tracers in radioguided surgery:

The role of fluorescent and hybrid tracers in radioguided surgery in urogenital malignancies

Having a great week in Göttingen at the #EMIM2021 - first in person conference this year for our group. Now heading back to the lab with new impressions and creative ideas.

Our research group is growing. We have the pleasure to welcome Lennard as PhD student in our team. We wish him a successful scientific start in Lausanne.

We welcome Radmila as Postdocrotal Fellow at Agora. With her previous experience in the field of radiochemistry, she will be a great addition in our research team. 

Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors.

We’re starting into 2021 with very good news:  Our collaborative Grant proposal « PREDICT » (co-investigators: Prof. Vincent Zoete, Prof. Niklaus Schaefer) has been accepted by the San Salvatore Foundation and will receive funding for 2021-2023 !

Proud to announce: Our collaborative Oncosuisse Grant proposal « RADIATION » (co-investigators: Dr. Steven Dunn, Dr. Melita Irving, Prof. Vincen Zoete) has been accepted and will receive funding for 2021-2023 !

We recommend the recently published review of Professor Magret Schottelius addressing the role of CXCR4 in cancer:

At the bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer

We gratulate Prof Magret Schottelius for the new promising publication:

A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency

A clinical study performed with [99mTc]Tc-PSMA I&S is accessible now:

[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center

A new publication is available now:

From Theranostics to Immunotheranostics: the Concept

Finally! The first important step is accomplished. We now have a fully equipped laboratory, and this milestone is celebrated with a classical Swiss Apéro. The lab is now officially ready for synthesis and first preclinical experiments.

Thanks to all those who have supported us!

A new publication highlights an underestimated preclinical issue:

“Luke! Luke! Don’t! It’s a trap!”—spotlight on bias in animal experiments in nuclear oncology

We welcome Severin as new member in our research team. With his previous experience as a radiochemist, he will be a great asset to establish our research group. Finally, we wish him a pleasant scientific start in Lausanne.

First equipment arrives, our lab grows now from day to day - and we will be soon ready to cook (synthesize) :)

We welcome Sebastian as new PhD candidate in the TRS research group and whish him a pleasant scientific start in the new lab!

The TRS (Translational Radiopharmaceutical Sciences) research group is established and ready to get started under the expertise of Prof. Dr. Margret Schottelius.